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INTRODUCTION
The prostate gland consists of a complex glandular ductal
system lined with exocrine epithelial cells, basal cells and neu-
roendocrine cells embedded in a fibromuscular stromal matrix
(1, 2). The secretory epithelial cells in the prostate produce
the bulk of human seminal fluid. Neuroendocrine cells in
the prostate gland are serotonin- and peptide-containing cells,
which are part of a dispersed neuroendocrine regulatory sys-
tem, called APUD (amine precursor uptake and decarboxy-
lation) system. The functional role of prostate neuroendocrine
cells are supposed to be involved in normal prostate growth,
benign hyperplasia and cancer development (3-5).
The physiological and pathophysiological function of pro-
state is under the control of autonomic nervous system as well
as the hormonal state (6, 7). The secretion of prostatic fluid,
for example, is positively regulated by acetylcholine via mus-
carinic receptors in the secretory epithelial cells (8, 9). On
the other hand,  1-adrenergic stimulation induces the smooth
muscle contraction that would help the secreted fluid to be
expelled from the lumen of gland (8, 9). The  1-AR mediat-
ed smooth muscle contraction has been the rational ground
for the use of  1-blockers to relieve the symptom of benign
prostatic hyperplasia.
In previous studies, we firstly investigated the physiolog-
ical and pharmacological properties of various types of single
prostate cells encompassing secretory epithelial cell (11, 12),
smooth muscle cell (13) and neuroendocrine cells (14-16).
After an enzymic digestion of the ventral lobe of rat prostate,
the chromogranin-A positive round-shaped cells (putative
neuroendocrine cells) are discriminated from the columnar
epithelial cells. The putative rat prostate neuroendocrine cells
(RPNECs) display typical properties of excitable cells; spon-
taneous action potentials and voltage-gated Ca2+currents (14).
The pharmacological studies demonstrate that the RPNECs
functionally express  1- and  2-adrenergic receptors that are
linked to the release of stored Ca2+ and the inhibition of N-
type Ca2+ channels, respectively (15). In addition, both iono-
tropic P2X1 receptors and metabotropic P2Y2 receptors are
present in RPNECs and the stimulation of which increases
[Ca2+]c via fast Ca2+ influx and stored Ca2+ release, respectively
(16). 
Compared with the understanding of adrenoceptors and
purinoceptors, relatively little is known about the cholinergic
effects on prostate neuroendocrine cells. In the neuroendocrine
cells from the human adenomatous prostate, the release of
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M3 Subtype of Muscarinic Receptors Mediate Ca
2+ Release from 
Intracellular Stores in Rat Prostate Neuroendocrine Cells
Our previous studies document the expression of adrenoceptors and purinoceptors
in the rat prostate neuroendocrine cells (RPNECs). However, a direct investigation
of the receptors for acetylcholine (ACh) is still lacking in the prostate neuroendocrine
cells. RPNECs were freshly isolated from the ventral lobes of rat prostate by using
collagenase. Effects of ACh and various muscarinic antagonists on the intracellular
Ca
2+ concentration ([Ca
2+]c) were investigated by using the fura-2 spectrofluorimetry.
Single-cell RT-PCR analysis was applied to identify the transcripts for the muscarinic
receptor subtypes. ACh (5  M) induced a sharp transient increase in the [Ca
2+]c of
RPNECs, which was independent of the extracellular Ca
2+. In the same RPNECs,
high KCl (60 mM), phenylephrine (5  M), UTP (P2Y1/2 agonist, 50  M), and  , -
meATP (P2X1/3 agonist, 0.5  M) also increased the [Ca
2+]c. The ACh-induced [Ca
2+]c
change ( [Ca
2+]c) was blocked by atropine or by para-fluorohexahydrosiladifenidol
(M3 antagonist, 0.3  M), but not by telenzepine (M1 antagonist, 1  M) and himbacine
(M2 and M4 antagonist, 1  M). The single-cell RT-PCR demonstrated the selective
expression of mRNAs for M3 in RPNECs. In summary, RPNECs express M3 mus-
carinic receptors that are linked to the release of Ca
2+ from intracellular stores. The
Ca
2+ signals of RPNECs might mediate the parasympathetic regulation of prostate
gland. 
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histamine is increased two fold by carbachol, which is blocked
by the pretreatment with atropine (17). This study indicates
the presence of muscarinic receptors in prostate neuroendo-
crine cells. However, more direct investigation about the
effects of acetylcholine on the prostate neuroendocrine cells
and the knowledge of the subtype(s) of muscarinic receptors
are still lacking.
In the present study, employing the fura-2 fluorescence
measurement, we investigated the effects of ACh on [Ca2+]c
in freshly isolated RPNECs. Also, a single cell RT-PCR anal-
ysis was performed to elucidate the presence of transcripts
for a specific subtype of muscarinic receptors in RPNECs.
MATERIALS AND METHODS
Cell isolation
All procedures on experimental animals were performed in
accordance with the guidelines of the Institutional Animal
Care and Use Committee (IACUC) of Sungkyunkwan University.
Male Sprague-Dawley rats (350-400 g) were killed by 100%
CO2 inhalation and the ventral lobe of the prostate gland re-
moved rapidly thereafter. The fibrous capsule was removed
and the tissue was cut with scissors into small pieces (1-2 L  )
in a phosphate-buffered Ca2+-free Tyrode’s solution. The tis-
sue was digested for 25 min at 37℃ in Ca2+-free Tyrode’s
solution containing collagenase (2 mg/mL, Wako, Japan),
trypsin inhibitor (1 mg/mL, Sigma, St. Louis, MO, U.S.A.),
bovine serum albumin (3 mg/mL, Sigma) and dithiothreitol
(DTT, 1 mg/mL, Sigma). Following digestion and subse-
quent removal of supernatant, tissue segments were trans-
ferred to fresh Tyrode’s solution and agitated gently using a
fire-polished wide bore (1-2 mm) Pasteur pipette. Isolated
cells were isolated daily then stored in fresh solution at 4℃
for up to 6 hr. Dispersed cells were moved into the experiment
chamber and examined by using an inverted microscope (IX-
70, Olympus, Japan). After the digestion procedure, most
of isolated single cells had elongated columnar shape, a typ-
ical feature of secretory epithelial cells. Besides columnar
cells, we could identify round or oval shape cells with rela-
tively dark cytoplasm that were regarded as RPNECs in the
present study. The putative RPNECs were carefully discrimi-
nated from damaged or swollen epithelial cells that showed
also round or oval shapes but with pale cytoplasm. The reli-
ability of above criteria for identifying RPNECs were assured
by constant responses of chosen cells to noradrenaline in [Ca2+]c
or to  , -meATP. Such responses to NA and , -meATP
are not observed in columnar epithelial cells (15, 16).
Intracellular Ca2+ measurement
Dispersed single cells were loaded with acetoxymethyl ester
form of Fura-2 (2  M) in the Ringer’s solution for 20 min at
room temperature and then washed out with fresh solution.
The putative RPNECs were identified as above criteria, and
the region of interest for Fura-2 experiment was set so that
the fluorescence from the single RPNEC could be collected
selectively. The recording of [Ca2+]c was performed with a
microfluorimetric system consisting of an inverted fluores-
cence microscope (Olympus IX-70, Japan) with a dry-type
fluorescence objective lens (×40, NA 0.85), a photomultiplier
tube (type R 1527, Hamamatsu, Japan) and Deltascan illumi-
nator (Photon Technology International Inc, Monmouth, NJ,
U.S.A.). Light was provided by a 75-W xenon lamp (Ushino,
Tokyo, Japan) and a chopper wheel alternated the light path
to monochromators (340 and 380 nm) with a frequency of
5 Hz, and intensity of emitted light at 510 nm was measured.
As a measure of [Ca2+]c the fluorescence emission ratio at 340
nm/380 nm excitation (F340/380) is presented.
Single cell RT-PCR
To synthesize first strand cDNA, RPNECs were collected
individually by using microelectrodes with inner diameter
of about 25-30  m on the stage of inverted microscope for
the patch clamp. After aspiration, the cell was expelled from
the pipette into ice cooled 0.2 mL tubes, which contained 2
units of RNase-free DNase (Takara Bio Inc., Shiga, Japan),
40 units of ribonuclease inhibitor (Takara Bio Inc., Otsu, Shiga,
Japan), 50 mM Tris-HCl (pH 8.3), 3 mM MgCl2, 75 mM
KCl, and 100 mM DTT. The reaction mixture was incubated
at 37℃ for 30 min, followed by 95℃ for 5 min. And then
reverse transcription reaction was performed in the presence
of 0.8  g of oligo (dT)15 (Roche Applied Science, Indianapo-
lis, IN, U.S.A.), 10 mM each of dATP, dTTP, dGTP and dCCT
(Roche Applied Science), and 200 units of SuperScriptTM
reverse transcriptase (Invitrogen Life Technologies, Carlsbad,
CA, U.S.A.). The reaction proceeded for 10 min at 25℃,
and for 50 min at 42℃, followed by a 15-min step at 70℃
to inactivate the SuperScriptTM reverse transcriptase. 
Two rounds of PCR (PTC-0150 MiniCyclerTM; MJ Research
Inc., Waltham, MA, U.S.A.) were performed with outer
primers and nested primers of M1, M2, M3, M4, and M5
muscarinic receptors of rat (18, 19). First strand cDNA was
used for the first PCR amplification. This mixture was then
used for the second nested PCR amplification. PCR reactions
were carried out using the 2.5 units of Taq polymerase (Takara
Bio Inc.) containing of 10 mM Tris-HCl (pH 8.3), 50 mM
KCl, 1.5 mM MgCl2, 10 mM each of dATP, dTTP, dGTP
and dCCT, 100 pM each of sense and antisense primers, and
DNA template. Temperature cycling proceeded as follows:
1 cycle at 95℃ for 5 min and 45 cycles at 95℃ for 60 sec,
50℃(for M4) or 55℃(for M1, M2, M3, M5) for 60 sec, and
72℃ for 60 sec, followed by 72℃ for 10 min. PCR prod-
ucts were then subjected to gel electrophoresis on a 1.5%
agarose gel containing ethidium bromide. Primers for the
PCR of M1, M2, M3, M4, and M5 are as follows: M1 sense, 5′ -258 J.K. Kim, S.J. Kim, J.E. Lee, et al.
GCA CAG GCA CCC ACC AAG CAG-3′ ; M1 antisense,
5′ -AGA GCA GCA GCA GGC GGA ACG-3′ ; M2 sense,
5′ -GGC AAG CAA GAG TAG AAT AAA-3′ ; M2antisense,
5′ -GCC AAC AGG ATA GCC AAG ATT-3′ ; M3 sense, 5′ -
CAC AGG CAG TTC TCG AAG CT-3′ ; M3 antisense, 5′ -
AGG ACG GTA GCT TGG TAG AG-3′ ; M4 sense, 5′ -AGT
GCT TCA TCC AGT TCT TGT CCA-3′ ; M4 antisense, 5′ -
CAC ATT CAT TGC CTG TCT GCT TTG-3′ ; M5 sense,
5′ -CTC ATC ATT GGC ATC TTC TCC A-3′ ; M5 antisense,
5′ -GGT CCT TGG TTC GCT TCT CTG T-3′ ; M1 nested
sense, 5′ -CCT CCC AAA AGC TCC CCA-3′ ; M1 nested
antisense, 5′ -TGT CCC GGA AGG CTT TGT-3′ ; M2nested
sense, 5′ -GAA GGA AAA GAA GGA ACC TGT-3′ ; M2
nested antisense, 5′ -GTC CTG GTC ACT TTC TTT TCC-
3′ ; M3 nested sense, 5′ -CTC GAA GCT GTA GCA GCT
ATG-3′ ; M3 nested antisense, 5′ -GGA GCT ATG GCC
TGG ACG CTT GAG G-3′ ; M4nested sense, 5′ -ACC CGG
CAG TGA CCT TTG-3′ ; M4nested antisense, 5′ -TTA CAA
TTT GAA TCT TGG ACC AT-3′ ; M5nested sense, 5′ -GAA
CCT CTA CAC GAC CTA CAT C-3′ ; M5 nested antisense,
5′ -CCC GGT AGA TCC GGC AGT AG-3′ .
Solutions and chemicals
All the experiments were performed in phosphate-buffered
saline (PBS) containing 145 mM NaCl, 1.6 mM K2HPO4,
0.4 mM KH2PO4, 1 mM MgCl2, 2 mM CaCl2 and 5 mM
D-glucose at pH 7.4 titrated with NaOH. CaCl2 was omit-
ted in the enzymatic isolation of single prostate cells.
The following drugs were used: acetylcholine chloride, para-
fluoro-hexahydrosiladifenidol (pF-HHSiD) hydrochloride,
4-hydroxy-2-butynyl-1-trimethylammonium-m-chlorocar-
bamilate chloride (McN-A-343), telenzepine dihydrochloride,
himbacine hydrochloride, and 4-diphenyl acetoxy-N-methyl
piperidine methobromide (4-DAMP) (Sigma-Aldrich, Seoul,
Korea). All other drugs except pF-HHSiD were dissolved in
distilled water. Stock concentration (1 mM) of pF-HHSiD
was prepared in dimethylsulfoxide. Dilutions to working con-
centrations were made in PBS solution.
Data analysis and statistics
The data are presented as original recordings, current-voltage
(I-V) curves, histograms and bar graphs of mean±S.E.M.
(for n cells tested). When necessary, Student’s t-test for paired
samples was applied, since the control and test recordings
were made from the same cell. Probability value below 0.05
(p<0.05) was regarded as significant.
RESULTS
ACh-induced increase in [Ca
2+]c
Among the dispersed prostate cells, we could discriminate
the putative neuroendocrine cells with a round shape and rela-
tively dark cytoplasm from the columnar epithelial cells and
the thin smooth muscle cells as has been described previously
(12, 14-16). The Fura-2 fluorescence ratio (F340/380, see Mate-
rials and methods) was measured in RPNECs. An application
of ACh (5  M) induced a transient increase in [Ca2+]c which
is followed by a plateau-like level above the control (Fig. 1).
In the same RPNECs, the effects of high K
+ (60 mM), phe-
nylephrine (PhE, 5  M), UTP (20  M), and  , -meATP (0.5
M were confirmed since the adrenergic and purinergic (both
P2X and P2Y) stimulations as well as the membrane depo-
larization increase the [Ca2+]c of RPNECs (15, 16). Summary
of Ca
2+responses to various stimuli demonstrate that the effect
of ACh is stronger than the KCl-induced depolarization (p<
0.05) and similar with the responses to PhE, UTP and  , -
meATP (Fig. 1B).
The ACh-induced increase in [Ca
2+]c (ACh- [Ca2+]c) was
not affected by the removal of extracellular Ca
2+ (Fig. 2A),
indicating a mechanism of Ca
2+ release from the intracellular
stores (e.g. endoplasmic reticulum). In the adrenal chromaf-
fin cells, ACh activates nicotinic ionotropic receptors that
induce membrane-depolarization as well as direct Ca
2+ influx
(20). In RPNECs, however, the pretreatment with atropine
(1  M), a representative antagonist of muscarinic receptors,
completely blocked ACh- [Ca2+]c (Fig. 2B). This result ex-
Fig. 1. Ca
2+ responses to various agonists in RPNECs. (A) repre-
sentative traces of F340/380 demonstrating the effects of PhE (5  M),
UTP (20  M), ACh (5  M) and  , -meATP (0.5  M) on [Ca
2+]c of
an RPNEC. The results demonstrated in this figure were obtained
from the same cell. (B) Summary of the extent of changes in fluores-
cence ratio ( F340/380) by various agonists and potassium-induced
depolarization (KCl 60 mM). The number of tested cells are five
to ten for each bar, respectively. 
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cludes the involvement of nicotinic ACh receptors in RPNECs
(Fig. 2B).
To identify the subtype(s) of muscarinic receptors in RP-
NECs, effects of subtype-specific pharmacological agents were
examined (21, 22). A pretreatment with telenzepine (1  M),
an M1-sepecific antagonist, did not affect the amplitude of the
ACh- [Ca2+]c (93±9.0% of control, n=4, Fig. 3A). Also,
the M1-specific agonist (McN-A-343 1  M) had no effect
on the [Ca2+]cof RPNECs (Fig. 3B, n=3). In the same RPNEC
where telezepine had negligible effect, a pretreatment with
pF-HHSiD (0.3  M), a specific M3 antagonist, completely
blocked the ACh- [Ca2+]c in a reversible manner (Fig. 3A,
n=5). A lower concentration of pF-HHSiD (0.1  M) showed
partial inhibitory effects (38±20.5% of control, n=4). Also,
4-DAMP (1  M), another subtype-selective antagonist for M3
receptors, blocked the ACh- [Ca2+]c (n=2, data not shown).
Finally, himbacine (1  M), an antagonist for M2and M4recep-
tors, showed a partial inhibitory effect on the ACh- [Ca2+]c
(Fig. 3C, 64±9.1% of control, n=5).
Next, to further identify the muscrainic receptor subtype
in RPNECs, a nested RT-PCR was performed with isolated
RPNECs (see Materials and methods). Among the tested
primers, only the M3-specific pairs showed a positive result
(Fig. 4). The same results were confirmed in three separate
experiments.
DISCUSSION
The present study demonstrates the existence of M3 sub-
type of muscarinic receptors in the RPNECS. The stimula-
tion of muscarinic receptors evoked a strong release of Ca
2+
from intracellular stores of RPNECs, similar with the actions
of P2Y2 and  1-adrenergic stimulations in the same neuroen-
docrine cells (15, 16). Muscarinic ACh receptors belong to a
family of G protein-coupled receptors. Molecular cloning
studies have identified five muscarinic subtypes that are highly
homologous but distinct gene products. Among them the
M1, M3 and M5 receptors are coupled to Ca2+/phospholipid
Fig. 2. ACh stimulates muscarinic receptors coupled to store Ca
2+
release in RPNECs. (A) ACh induced increase in F340/380 is repeated
in the presence and absence of extracellular Ca
2+. (B) The ACh-
induced  F340/380 is completely blocked by the application of at-
ropine (1  M), which is partially reversed by washout of atropine. 
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second messenger system (22).
The prostate is richly innervated by both noradrenergic
and cholinergic fibers (7). Cholinergic stimulations are known
to regulate diverse physiological functions such as regulating
the force and rate of heart, smooth muscle contraction, glan-
dular secretory activity, cell growth and proliferation (23, 24).
The majority of muscarinic receptors in the prostate is locat-
ed in the glandular epithelium but is also detectable in stro-
mal tissue (25, 26). The presence of M3 muscarinic receptors
in rat prostate has been previously suggested from the radio-
ligand binding assay and the density of M3 receptors decreases
in aged rats (27). However, that study was performed with
the whole prostate gland whereas our present study demon-
strates the specific presence of M3 receptors in the neuroen-
docrine cells.
Consistent with the major location of muscarinic recep-
tors, in vivo activation of muscarinic receptors within the
prostate gland causes glandular secretion in the dog and rat
(9, 10, 28). In fact, the stimulation of secretory epithelial cells
of rat prostate with ACh induced an increase of [Ca2+]c with
concomitant activations of K
+ channels and Cl
- channels, both
are indispensable for the fluid secretion in various exocrine
glands (11, 12). Muscarinic receptor activation also stimu-
lated exocrine secretion of epidermal growth factor in the rat
prostate (29). Acetylcholine also causes contraction of prostate
smooth muscle from rabbits, pigs, rats and guinea pigs (30-
32). However, the contractile effect often requires very high
concentration of ACh (e.g. >0.1 mM in guinea pig) and is
much smaller than the contractile responses produced by  -
adrenoceptor agonists.
Recently, there is evidence that muscarinic receptor activa-
tion plays a role in cell growth in the prostate gland, and the
mitogenic effects of muscarinic stimulation has been proposed
(7, 23). Also, carbachol was found to increase [3H]-thymidine
uptake in the prostate tumour LNCaP cell line (23). Consid-
ering the potential role of neuroendocrine cells in the growth
of prostate gland, the regulation of paracrine/endocrine secre-
tion from the neuroendocrine cells by autonomic nerves could
be a crucial step in physiological functioning of the prostate
gland. The present study focuses on the effects of muscarinic
stimulations on the Ca2+ signaling in RPNECs. In RPNECs,
the stimulation of  1 adrenaline receptors changes the mem-
brane potential as well as triggering the InsP3-induced Ca2+
release mechanism (12, 33).
The subtypes of muscarinic receptor in the prostate appear
to be species dependent. The reported subtypes responsible
for the modification of contractile responses are M1, M2 and
M3 for guinea pig, dog and rat prostates, respectively (24).
The presence of M3 subtype in rat prostate was deduced from
the binding studies and contractile responses to carbachol and
muscarinic antagonists. However, a more rigorous antibody
study combined with RT-PCR analysis suggests a regional
difference depending on the lobe of prostate; the ventral lobe
predominantly express M3 receptors whereas the dorsolateral
lobes express M2 receptors in rat prostate (34). The neuroen-
docrine cells investigated in our present study were obtained
from the ventral lobes of rat prostate, and the conclusion of
M3 receptors in RPNECs is consistent with the previous study
of the general pattern of muscarinic receptors in the whole
gland (27).
In summary, the RPNECS express M3subtype of muscarinic
receptors, the stimulation of which evoked a strong Ca2+ sig-
nal. Considering the general role of neuroendocrine cells in
visceral organs, a part of the physiological effects triggered by
acetylcholine released from terminal nerves inside the prostate
may be mediated by the stimulation of neuroendocrine cells.
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